Amoxapine/Dipyridamole

阿莫沙平/双嘧达莫

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAmoxapine/Dipyridamole
Drug Alias Name阿莫沙平+双嘧达莫Amoxapine+Dipyridamole双嘧达莫+阿莫沙平Dipyridamole/Amoxapine双嘧达莫/阿莫沙平 +[7] 
ClassificationSmall molecules
Mechanisms of ActionMonoamine reuptake inhibitor3',5'-cyclic phosphodiesterase inhibitors
TargetsMonoamine transporters3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsPeriodontal DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AmoxapineDipyridamole
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCombinatorx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCombinatorx
Active IndicationsN/A
Inactive IndicationsPeriodontal DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A